Search Results

2023 Pipeline Report.

• Authors : Broderick, Jason M.

Subjects: THERAPEUTIC use of antineoplastic agents; DRUG approval; BLADDER tumors

• Source: Urology Times. Dec2023, Vol. 51 Issue 12, p10-12. 3p.

Record details

FDA Approves Bispecific Antibody for Small Cell Lung Cancer.

Subjects: THERAPEUTIC use of antineoplastic agents; THERAPEUTIC use of monoclonal antibodies; INVESTIGATIONAL drugs

• Source: Formulary Watch. 5/17/2024, p1-1. 1p.

Record details

FDA Grants Full Approval to Elahere.

Subjects: THERAPEUTIC use of antineoplastic agents; FOLIC acid metabolism; THERAPEUTIC use of monoclonal antibodies

• Source: Formulary Watch. 3/25/2024, p2-2. 1p.

Record details

Procurement of medicines to treat cancer, 2015-2020, China.

• Authors : Mengyuan Pan; Shuchen Hu; Jieqiong Zhang

Subjects: THERAPEUTIC use of antineoplastic agents; HEALTH policy; ESSENTIAL drugsCHINA

• Source: Bulletin of the World Health Organization. Dec2022, Vol. 100 Issue 12, p758-768. 11p.

Record details

Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.

• Authors : Tang, Ling-Long (AUTHOR); Guo, Rui (AUTHOR); Zhang, Ning (AUTHOR)

Subjects: THERAPEUTIC use of antineoplastic agents; RESEARCH; CLINICAL trials

• Source: JAMA: Journal of the American Medical Association. 8/23/2022, Vol. 328 Issue 8, p728-736. 9p.

Record details

FDA Approves Lilly's BTK Inhibitor for Rare Blood Cancer.

Subjects: THERAPEUTIC use of antineoplastic agents; DRUG approval; MEDICAL care costsUNITED States

• Source: Formulary Watch. 1/28/2023, p1-1. 1p.

Record details

PARP inhibitors: What urologists need to know.

• Authors : ANTONARAKIS, EMMANUEL S.

Subjects: THERAPEUTIC use of antineoplastic agents; PREVENTION of drug side effects; ANTINEOPLASTIC agents

• Source: Urology Times. Feb2021, Vol. 49 Issue 2, p1-20. 4p.

Record details

FDA Approves First Targeted Treatment for Myeloid/Lymphoid Neoplasms.

Subjects: THERAPEUTIC use of antineoplastic agents; DRUG approval; FIBROBLAST growth factors

• Source: Formulary Watch. 8/27/2022, p1-1. 1p.

Record details

Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.

• Authors : Jonasch, Eric (AUTHOR); Donskov, Frede (AUTHOR); Iliopoulos, Othon (AUTHOR)

Subjects: THERAPEUTIC use of antineoplastic agents; RENAL cell carcinoma; PROTEINS

• Source: New England Journal of Medicine. 11/25/2021, Vol. 385 Issue 22, p2036-2046. 11p.

Record details

"Encouraging" disease-free survival data are seen with avelumab/axitinib: Combination induced a partial response in 30% of patients, data indicate.

• Authors : BRODERICK, JASON M.

Subjects: THERAPEUTIC use of monoclonal antibodies; THERAPEUTIC use of antineoplastic agents; RENAL cell carcinoma

• Source: Urology Times. Apr2022, Vol. 50 Issue 4, p24-24. 1p.

Record details